Krystal Biotech, Inc.KRYSNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+23.6%
5Y CAGR+61.9%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+23.6%/yr
vs +108.0%/yr prior
5Y CAGR
+61.9%/yr
Recent deceleration
Acceleration
-84.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
11.1x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $146.74M | +29.1% |
| 2024 | $113.69M | +15.5% |
| 2023 | $98.40M | +26.6% |
| 2022 | $77.73M | +92.5% |
| 2021 | $40.39M | +205.7% |
| 2020 | $13.21M | +104.4% |
| 2019 | $6.46M | +55.6% |
| 2018 | $4.16M | +165.7% |
| 2017 | $1.56M | +289.1% |
| 2016 | $402000.00 | - |